Check-Cap (MBAI) Gains from Sales and Divestitures (2023 - 2024)
Check-Cap (MBAI) posted Gains from Sales and Divestitures of $351.0 for Q4 2024, down 94.24% sequentially from $6092.0 in Q4 2023, and down 94.24% YoY from $6092.0 in Q1 2024.
Check-Cap (MBAI) Gains from Sales and Divestitures (2023 - 2024) Analysis & Trends
Check-Cap (MBAI) has 2 years of Gains from Sales and Divestitures data on file, last reported at $351.0 in Q4 2024.
- Quarterly Gains from Sales and Divestitures fell 94.24% year-over-year to $351.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $351.0 (down 94.24% YoY) and the FY2024 annual result came in at $351.0, down 94.24% from the prior year.
- Gains from Sales and Divestitures retreated to $351.0 in Q4 2024 per MBAI's latest filing, from $6092.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $6092.0 in Q4 2023, with the low at $351.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Check-Cap | 7.73 Mn | 6.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 351.00 |
| Dec 31, 2024 | 351.00 |
| Dec 31, 2023 | 6,092.00 |
| Dec 31, 2023 | 6,092.00 |